Targeting alcohol-opioid co-use among young adults with a new mobile health tool
Official title: Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
Run by Brown University · NCT07663448 · Data updated 2026-11-12
A mobile health app is being tested to help young adults reduce drinking and opioid use when they occur together.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 25 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Brown University Academic / other |
| Locations | 1 site (Providence, Rhode Island) |
| Status | Recruiting |
| Started | June 8, 2026 |
| Main results expected | April 30, 2027 |
| Study ends | April 30, 2027 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT07663448 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Young adults aged 18–25 who are interested in reducing their alcohol-opioid co-use and report regular co-use (at least 1 day per week) are suitable.
✕Probably not a fit
Individuals not seeking to change their co-use or those outside the 18–25 age range may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This project develops and pilots an adaptive mHealth intervention designed for 18- to 25-year-olds who use alcohol and opioids together. The study uses ecological momentary assessment to understand real-time patterns of co-use and to inform the app's features. The goal is to create a practical tool that can reach young adults not currently in treatment and support reductions in co-use and related harms. The intervention is led by Brown University with collaboration from NIAAA and will be implemented at Brown University’s Center for Alcohol and Addiction Studies in Providence, RI. No phase is specified, and the work emphasizes development and pilot testing of the technology and user experience.
Why it matters
Potential benefit: If successful, the app could provide an accessible way for young adults to reduce alcohol-opioid co-use and related health risks.
How similar studies have gone: There is limited prior work specifically targeting alcohol-opioid co-use with mHealth, making this approach relatively novel but supported by the broader potential of EMA-informed digital interventions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Ages 18 to 25 years, inclusive 2. Self-report interest in reducing their alcohol-opioid co-use - outside a research study, people who do not wish to change their co-use are unlikely to download and use an mHealth app designed to reduce co-use. It is important to recruit participants who most closely resemble the intended users of the eventual mHealth intervention. This is defined as reporting any alcohol-opioid co-use goal (i.e., not selecting "No goal" in response to the alcohol-opioid co-use goal question at the screening visit). 3. Self-report engaging in simultaneous alcohol-opioid co-use (i.e., use of both substances within two hours) ≥ 1 day/week on average in the past 28 days (i.e., at least 4 co-use events in the past 28 days). This requirement will ensure that we observe sufficient use episodes where the pharmacological effects of alcohol and opioids overlap to evaluate project aims. 4. Able to understand written and oral instructions in English, communicate understanding of the consent form, and provide written informed consent. 5. Complete all assessments required at screening. 6. Agree to the schedule of visits, verbally acknowledge that he/she/they will be able to attend each scheduled visit, participate in phone visits and that he/she/they does not have any already scheduled events or a job that may substantially interfere with study participation. 7. Own a smartphone with data plan. Almost all participants (98%) in our preliminary work owned a smartphone with data plan. 8. Currently reside in the United States of America. Exclusion Criteria: 1. Pregnant or nursing 2. Current suicidality 3. History of psychosis
Where it's running
-
Brown University Center for Alcohol and Addiction Studies
Providence, Rhode Island, United States Recruiting
Study contacts
- Study coordinator: Robert Miranda, PhD
- Email: Robert_Miranda_Jr@brown.edu
- Phone: 401-863-6658
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if stopping alcohol can lower blood pressure and heart risk in adults who drink and have hypertension
This study tests whether abstaining from alcohol for 8 weeks can improve blood pressure and heart-health markers in adults who regularly drink and have high blood pressure.
-
Alcohol, Breast Milk, and Metabolism in Lactating Women
This study tests whether breast tissue locally metabolizes alcohol by comparing alcohol-related markers in blood and breast milk from lactating women after low-level alcohol exposure.
-
Serratus vs Erector Spinae Block for Pain After Unilateral Breast Surgery
This trial tests whether serratus posterior superior intercostal plane block or erector spinae plane block reduces chronic pain 3 months after unilateral breast surgery in adult women.
-
Using mHealth to Help Black Adults in the Midwest With Opioid/Stimulant Use and Mood Symptoms
This study tests a mobile health program to support recovery and mood in Black adults who use opioids or stimulants and are seeking treatment.
-
Ketogenic Diet and Alcohol Intoxication: Can ketosis affect brain function and alcohol response
This study tests whether a 4‑week ketogenic diet changes how the brain works and how the body handles alcohol in adults who drink regularly.
-
Reset Challenge: See if 30 days without alcohol reduces high-risk drinking
This 30-day mobile program tests whether people who drink heavily can cut back or stop drinking for a month, with a focus on those in Oklahoma.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.